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Bioactive Phytochemicals in Flaxseed - With Particular Emphasis 
on the Secoisolariciresinol Oligomer 
Abstract 
Flaxseed (Linum usitatissimum L.) is rich in health-promoting bioactive compounds. 
Among plant foods, flaxseed has the highest content of lignans, mainly in the form 
of secoisolariciresinol diglucoside (SDG). Flaxseed oil also has a very high 
concentration of the essential omega-3 fatty acid alpha-linolenic acid (ALA). This 
thesis presents studies on both SDG and ALA.  
An HPLC method for quantification of SDG in hydrolysed flaxseed extracts was 
developed and used to compare the SDG content in 29 flaxseed cultivars (6.1-13.3 
mg/g seed, dry weight). Full spectroscopic (NMR) data were obtained for two 
compounds, 4-O-β-D-glucopyranosyl-p-coumaric acid (CoAG) and 4-O-β-D-
glucopyranosyl-ferulic acid, eluting before SDG in the HPLC system developed. 
NMR analyses provided the first evidence that SDG in flaxseed is bound in a linear 
oligomeric structure with an average composition of five SDG residues interlinked 
by four 3-hydroxy-3-methyl glutaric acid residues (average size 4 kDa). 
Chromatographic (UHPLC, GPC, SPE) and spectroscopic (MALDI-TOF) analyses 
of seven different flaxseed cultivars showed that the size of the SDG oligomers 
differed among cultivars depending on seed SDG/CoAG ratios.  
In attempts to decrease the use of fish-based feeds in aquaculture, vegetable oils 
are being assessed as replacements for fish oil. However, this has hitherto resulted in 
decreased levels of the long-chain omega-3 fatty acids (n-3 HUFA) that make fish a 
healthy food choice for humans. Previous studies have shown that sesamin, a lignan 
from sesame seed, is able to increase conversion of ALA to n-3 HUFA in rainbow 
trout (Oncorhynchus mykiss) but less efficiently than expected when flaxseed oil, 
given its high ALA content, was used. In order to investigate whether high levels of 
ALA or possibly minor compounds in flaxseed oil could be responsible for the low 
n-3 HUFA formation, rainbow trout were fed diets containing purified flaxseed 
triacylglycerols (PFSO) with and without sesamin. However, it was found that 
PFSO was unable to increase ALA conversion compared with unaltered flaxseed oil 
and that PSFO with or without sesamin addition had the opposite effect to 
unaltered flaxseed oil with or without sesamin addition, respectively. The reasons 
for these effects are discussed. 
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Bioaktiva fytokemikalier i linfrö - Med särskild betoning på 
secoisolariciresinol-oligomeren 
Svensk sammanfattning 
Linfrö (Linum usitatissimum L.) innehåller höga halter av bioaktiva ämnen. Bland 
födoväxter har linfrö det högsta innehållet av lignaner, främst i form av 
secoisolariciresinol diglukosid (SDG). Linfröolja har också bland de högsta 
koncentrationerna av den essentiella omega-3 fettsyran alfalinolensyra (ALA). Den 
här avhandlingen presenterar arbeten om både SDG och ALA. 
En HPLC-metod för kvantifiering av SDG i hydrolyserade linfröextrakt 
utvecklades och användes för att jämföra innehållet av SDG i 29 linfrösorter (6.1–
13.3 mg/g frö, torrvikt). Vidare erhölls fullständiga spektroskopiska data för två 
föreningar, 4-O-β-D-glukopyranosyl-p-coumarsyra (CoAG) och 4-O-β-D-
glukopyranosyl-ferulasyra, som eluerades före SDG i den framtagna HPLC-
metoden. Med hjälp av olika NMR-tekniker lades de första bevisen fram för att 
SDG i linfrö var bundet i en linjär oligomer struktur innehållande ett genomsnitt av 
fem SDG-enheter sammanlänkade av fyra 3-hydroxy-3-metylglutarsyror (medelvikt 
4 kDa). Genom kromatografiska (UHPLC, GPC, SPE) och spektroskopiska 
(MALDI-TOF) jämförelser av sju linfrösorter visades att SDG-oligomerer har olika 
storlekar i olika linfrösorter beroende på fröernas SDG/CoAG-kvot.  
I och med ansträngningar att minska användningen av fiskbaserade foder i 
fiskodlingen görs försök att ersätta fiskolja i foder med vegetabiliska oljor. Det har 
dock hitills resulterat i minskade halter av de långkedjiga omega-3 fettsyror (n-3 
HUFA) som gör fisk till ett hälsosamt livsmedelsval för människor. Tidigare studier 
har visat att en lignan från sesamfrö, sesamin, har förmågan att öka omvandlingen av 
ALA till n-3 HUFA i regnsbågslax (Oncorhynchus mykiss) men, med tanke på 
linfröoljans höga innehåll av ALA, i mindre grad än väntat när linfröolja användes i 
fodret. För att undersöka huruvida den höga ALA-halten eller möjligen de 
”småkomponenter” som finns i linfröolja orsakar den låga ALA-omvandlingen, 
utfodrades regnbågslax med triacylglycerolfraktionen (PFSO) från linfröolja med 
eller utan tillsats av sesamin. Det visade sig dock att PFSO inte ökade ALA-
omvandlingen jämfört med hel linfröolja samt att PFSO med eller utan tillsatt 
sesamin, resulterade i omvända effekter jämfört med linfröolja med respekive utan 
tillsatt sesamin. Orsakerna till dessa effekter diskuteras.   
 
 
Hur kan det finnas så mycket att titta på i ett litet linfrö? 
Momma  
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Abbreviations 
AA  Arachidonic acid (20:4 n-6) 
ALA alpha-linolenic  acid/α-linolenic acid (18:3 n-3) 
aq. Aqueous 
13C NMR  Carbon NMR 
CoAG  p-coumaric acid glucoside 
COSY  Correlation spectroscopy (NMR) 
DFF  Defatted flaxseed flour 
DHA  Docosahexaenoic acid (22:6 n-3) 
DPA  Docosapentaenoic acid (22:5 n-3) 
EPA  Eicosapentaenoic acid (20:5 n-3) 
FeA Ferulic  acid 
FeAG  Ferulic acid glucoside 
FSO  Flaxseed oil  
FSO+S  Flaxseed oil + sesamin 
GC Gas  chromatography 
GLM  General Linear Model 
GPC  Gel permeation chromatography 
HDG Herbacetin  diglucoside 
HMBC  Heteronuclear multiple bond correlation (NMR) 
HMGA 3-hydroxy-3-methylglutaric  acid 
1H NMR  Proton NMR 
HPLC  High performance liquid chromatography 
HSQC-DEPT   Heteronuclear single quantum coherence - Distortionless 
enhancement by polarization transfer (NMR) 
HUFA  Highly unsaturated fatty acids (≥ 20 carbons and ≥ 3 double 
bonds) 
LA  Linoleic acid (18:2 n-6) 
LC-MS  Liquid chromatography mass spectrometry   12 
MALDI-TOF MS  Matrix Assisted Laser Desorption/Ionisation Time of Flight 
Mass Spectrometry 
MO  Mixed oil (sunflower + linseed oil, 6:4 v/v) 
MO+S  Mixed oil + sesamin 
MS Mass  spectrometry 
MW  Molecular weight (g/mol or Da) 
NMR  Nuclear magnetic resonance spectroscopy 
PFSO  Purified flaxseed oil 
PFSO+S  Purified flaxseed oil + sesamin 
PL Phospholipid 
SAS  Statistical Analysis System for Windows 
SD Standard  deviation 
SDG Secoisolariciresinol  diglucoside 
SECO Secoisolariciresinol 
SPE  Solid phase extraction 
TAG Triacylglycerol 
TOCSY  Total correlation spectroscopy (NMR) 
UHPLC  Ultra-high performance liquid chromatography   13 
1  Introduction 
Archaeological findings suggest that flax (Linum usitatissimum L.) has been 
used by humans for about 10,000 years. It was probably one of the first 
plants to be domesticated, around 6,000 years B.C. in Mesopotamia, as 
evidenced by findings of large flaxseeds resulting from irrigation of 
cultivated land. There are records of flaxseed being used in bread in Jordan 
and Greece 3,000 years ago. Flaxseed and flaxseed oil have been valued as 
foods and for medical purposes since ancient times (Vaisey-Genser and 
Morris, 2003). Flaxseed is now attracting increased interest as a food due to 
its high fibre content, high content of bioactive phenolic compounds 
(mainly lignans) and high content of the essential omega-3 fatty acid alpha-
linolenic acid (ALA) (Dean, 2003). However, in many countries there are 
restrictions on the amount of flaxseed that may be included in foods (Dean, 
2003) due to its content of cyanogenic compounds. The Swedish National 
Food Administration advises consumers to not eat more than two 
tablespoons of flaxseed per day, but an occasional intake of 3-10 tablespoons 
is not considered to entail any acute health risks (Livsmedelsverket, 2009). 
The five leading producers of flaxseed world-wide are, in decreasing order: 
Canada, China, India, USA and Ethiopia (FAOSTAT, 2007).  
Flaxseed is also sometimes called linseed. In North America, the names 
‘flaxseed’ and ‘linseed’ are used interchangeably, although there is a 
tendency to use the name flaxseed for seeds that are used for human 
consumption. In Europe, the name flax is used for plants that are grown for 
linen fibre, while linseed refers to seeds that are grown for technical and 
nutritional purposes (Vaisey-Genser and Morris, 2003). The term flaxseed is 
used throughout this thesis, which focuses on the two traits of flaxseed that 
have gained most attention during recent decades, namely its high lignan 
and ALA content. 
   14 
1.1  Flaxseed lignans 
In the 1970s, a class of compounds called lignans, especially abundant in 
fibre-rich parts of plants, was recognised by the National Cancer Institute 
(USA) as high-interest compounds with regard to antitumour activity 
(Hartwell, 1976; Barclay, 1976). A few years later, the enterolignans (also 
called mammalian lignans) enterolactone and enterodiol, which were 
identified as metabolic products of dietary plant origin, were discovered in 
human urine (Setchell et al., 1979; Setchell et al., 1980b; Stich et al., 1980; 
Setchell et al., 1981; Axelson et al., 1982). Their excretion in urine from 
human and vervet monkey females was shown to vary during the 
reproductive cycle, with a maximum during the luteal phase and early 
pregnancy. Their excretion was negatively correlated to that of oestrogen, 
suggesting a physiological function relating to hormone metabolism (Setchell 
et al., 1979; Stich et al., 1980; Setchell et al., 1980a; Setchell et al., 1981; 
Adlercreutz, 1984; Horwitz and Walker, 1984). This eventually led to the 
suggestion that fibre-rich plant foods containing hormone-like compounds 
such as lignans and isoflavonoids, also known as phyto-oestrogens, may 
influence oestrogen metabolism and reduce the incidence of breast and 
colon cancer and possibly other diseases (Setchell et al., 1981; Adlercreutz, 
1982, 1984; Horwitz and Walker, 1984; Adlercreutz, 1990). In plants, 
lignans are thought to act as growth regulators or as a defence against 
external threats (Ayres and Loike, 1990). The number of lignans identified is 
steadily increasing. Lignans come in a large number of structural variations 
and they have been shown to possess a wide variety of biological activities 
such as antitumour, antimitotic, inhibition of DNA and RNA synthesis, 
antiviral, inhibition of enzyme activity, anti-insect, antimicrobial and 
fungistatic (MacRae and Towers, 1984), which is why they are attracting 
much interest in research. 
Dietary sources of lignans include seeds, legumes, cereals, vegetables, 
berries, seaweed, tea and alcoholic beverages (Thompson et al., 1991; 
Namiki, 1995; Mazur et al., 1996; Mazur, 1998; Mazur and Adlercreutz, 
1998; Mazur et al., 1998a, b; Liggins et al., 2000; Mazur et al., 2000; Nurmi 
et al., 2003). Quantitative data on some lignans present in food are presented 
in Table 1. Flaxseed and sesame seed contain tens to thousands of times 
more lignans than most other edible plants (Table 1) and can therefore 
contribute significantly to lignan intake through the diet, even with 
moderate intakes.   15 
Table 1. Examples of lignan levels determined for some selected food plant products 
Source  Lignan   Level  
(ppm
1, fresh weight) 
Reference 
Flaxseed Secoisolariciresinol
2 6285-13680
3 Eliasson  et al., 2003 
Sesame seed  Sesamin    70-7120  Moazzami and Kamal-Eldin, 
2006 
Sunflower seed  Lariciresinol    7  Milder et al., 2005 
Rye Syringaresinol    35  Smeds  et al., 2007 
Wheat 7-hydroxymatairesinol    28  Smeds  et al., 2007 
Broccoli Lariciresinol    10  Milder  et al., 2005 
Strawberry Pinoresinol    2 Milder  et al., 2005 
Tea (blend)  Pinoresinol    0.3  Milder et al., 2005 
1Parts per million 
2Recalculated from secoisolariciresinol diglucoside 
3Dry weight 
 
Plant lignans are phenolic secondary metabolites with a basic structure 
consisting of two interlinked phenylpropanoid molecules (Figure 1a). There 
are two major classes of lignans, the dibenzylbutane lignans and the 
furanofuran lignans, of which secoisolariciresinol diglucoside (SDG) from 
flaxseed and sesamin from sesame seed are respective examples (Figure 1b 
and c). The prevailing lignan in flaxseed is secoisolariciresinol diglucoside 
(SDG; MW = 686.7 Da; Figure 1b) (Bakke and Klosterman, 1956; 
Chimichi  et al., 1999; Sicilia et al. 2003), which is often referred to as 
secoisolariciresinol or SECO, the aglycone of SDG (Mazur et al., 1996) 
depending on the method of analysis. In flaxseed, SDG exists in two 
isomeric forms, (+)-SDG and (-)-SDG, of which (+)-SDG is the major 
isomer (Bambagiotti-Alberti et al. 1994; Eliasson et al., 2003). Smaller 
quantities of matairesinol, isolariciresinol, lariciresinol, demethoxy-
secoisolariciresinol and pinoresinol have also been identified in flaxseed 
(Meagher et al., 1999; Sicilia et al., 2003). The lignan content in flaxseed 
differs between varieties, but has also been shown to depend on growing 
location and year (Westcott and Muir, 1996b; Thompson et al., 1997).  
There are only a few studies on the stability of SDG through food 
processing. The SDG content in bakery products, added as a supplement or 
present in flaxseed, has been shown to withstand normal baking procedures 
(Westcott and Muir, 1996b; Muir and Westcott, 2000; Hyvärinen et al., 
2006), and storage of bread for 1 week at room temperature or 1-2 months 
at -25 °C (Hyvärinen et al., 2006 a).   16 
 
Figure 1. a) The basic structure of lignans consisting of two interlinked phenylpropanoid 
molecules, b) secoisolariciresinol diglucoside, a dibenzylbutane lignan, c) sesamin, a 
furanofuran lignan. 
Strandås et al. (2008b) showed that the level of SDG in 17 breads containing 
flaxseed was in the expected range considering the amount of flaxseed 
added. They also showed that the SDG and the hydroxycinnamic acids 
deriving from the flaxseed in the bread correlated to each other in a similar 
way as they do in pure flaxseed. From these results it was concluded that 
SDG and hydroxycinnamic acids from flaxseed are not affected by bread-
making conditions (Strandås et al., 2008b). Added SDG has also been 
reported to be stable during heat treatment, fermentation and storage of 
dairy products such as yoghurt and ripened hard cheese, with the exception 
of whey drinks where a 25% loss occurred after 6 months of storage 
(Hyvärinen et al., 2006b). 
As well as lignans, flaxseed also contains other phenolic compounds such 
as phenolic acids and flavonoids. Free or bound phenolic acids that have 
been identified in flaxseed include p-coumaric acid, ferulic acid, caffeic acid, 
p-hydroxybenzoic acid, gentisic acid, salicylic acid, sinapic acid, syringic acid 
and vanillic acid (Kozlowska et al., 1983; Dabrowski and Sosulski, 1984). 
Glucosides of p-coumaric (CoAG), ferulic (FeAG) and caffeic acid have 
been detected in flaxseed (Westcott and Muir, 1996a; Westcott and Muir, 
2000; Eliasson et al., 2003; Struijs et al., 2007). Linocinnamarin (4-O-β-D-
glucopyranosyl-cinnamate; p-coumaric acid glucoside) was first isolated from 
flaxseed by Klosterman et al. (1955). The compound linusitamarin (methyl 
O
O
O
O
O
O
O
O
O
O
O
O
9'
8'
7'
1'
2'
3' 4'
5'
6'
1
2
3
4
5
6
7
8
9
OCH3
OH
HO
H3CO
O
H
H
O
1 2
3
4
5 O
CH2OH
OH
OH
6
HO
1
2
3
4
5 O
CH2OH
OH
OH
6
HO
9'
8'
7'
1'
2'
3' 4'
5'
6'
1
2
3
4
5
6
7
8
9
OCH3
OH
HO
H3CO
O
H
H
O
1 2
3
4
5 O
CH2OH
OH
OH
6
HO
1
2
3
4
5 O
CH2OH
OH
OH
6
HO
a) 
b) 
c)   17 
3-β-D-glucopyranosyl-5-methoxycinnamate) was identified by Luyengi et 
al. (1993). However, the structure of this compound was probably 
misinterpreted as far as the 3/5 substitution is concerned, which is a very 
uncommon substitution pattern (Westcott and Muir, 2000). It was more 
likely to be a ferulic acid glucoside (3-methoxy-4-O-β-D-glucopyranosyl-
cinnamate), as supported by NMR analyses performed by Westcott and 
Muir (2000). Variations in phenolic acid content in flaxseed are largely 
attributable to seasonal effects (Oomah et al., 1995). Flavonoids such as 
herbacetin diglucoside (HDG) and kaempferol diglucoside have also been 
identified in flaxseed (Qui et al., 1999). The flavonoid content has been 
shown to be influenced by both cultivar and environment (Oomah et al., 
1996). 
1.1.1  The lignan oligomer in flaxseed 
In flaxseed, SDG does not exist as a free compound but is bound in a ester-
linked oligomeric structure together with the hydroxycinnamic acid 
glucosides CoAG and FeAG (Bakke and Klosterman, 1956; Westcott and 
Muir, 2000; Struijs et al., 2008), the flavonoid HDG (Struijs et al., 2007), 3-
hydroxy-3-methylglutaric acid (HMGA) (Klosterman and Smith, 1954; 
Ford et al., 2001; Figure 2), and possibly other minor constituents.  
 
 
Figure 2. a) p-coumaric acid glucoside (MW=326 Da), b) ferulic acid glucoside (MW=356 
Da), c) 3-hydroxy-3-methylglutaric acid (MW=162 Da), d) herbacetin diglucoside 
(MW=626 Da). For numbering of glucose carbons, see Figure 1b. 
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The ester linkages are mainly between the C-6 hydroxyl groups of the 
glucose units of SDG (Figure 1) and the carboxylic groups of CoAG, FeAG 
or HMGA (Ford et al., 2001; Struijs et al., 2008; Figure 2), although FeA, 
i.e. the aglycone of FeAG, has been shown to bind also to the C-2 position 
of glucose (Struijs et al., 2008). Since HMGA possesses two carboxylic 
groups, it can bind to two glucose units from two separate SDG molecules, 
which means that the oligomer can elongate with SDG + HMGA in two 
directions. So far, there is only evidence of HMGA binding to one glucose 
residue in HDG, so it is still uncertain whether HDG is part of the 
backbone structure of the oligomer or whether it is a substituent (Struijs et 
al., 2007). There is no evidence of CoAG and FeAG binding to constituents 
other than the glucose units in the oligomer (Struijs et al., 2008). If CoAG 
or FeAG binds to the C-6 carbon in the glucose moiety of SDG or HDG it 
would serve as a terminal unit and thus block any further elongation of the 
oligomer in that direction. Struijs et al. (2009) therefore postulated that the 
size of the oligomer is determined by the level of inclusion of CoAG and 
FeAG. However, the molecular size distribution is wide, as shown by the 
single broad peak or ‘hump’ resulting from HPLC analyses of unhydrolysed 
extracts. As this peak is transformed to several sharp peaks upon alkaline 
hydrolysis (Westcott and Paton, 2001), its shape cannot be attributed to the 
chromatographic method. Instead, the broadness is the result of a wide mass 
distribution and/or differences in polarity between molecular species in the 
extract. A wide size distribution has also been shown by matrix-assisted laser 
desorption and ionisation time of flight mass spectroscopy (MALDI-TOF 
MS) performed on the unhydrolysed flaxseed extract (Struijs et al., 2009).  
Strandås et al. (2008a) fractionated the oligomeric extract according to 
polarity by solid phase extraction (SPE) by elution with 50, 60 and 70 % 
aqueous methanol and found that the 60% fraction was the largest fraction 
by mass and that its composition was most similar to that of the whole 
extract. It was also shown that when moving from 50% to 70% methanol, 
the relative content of SDG increased whereas the relative content of CoAG 
and FeAG decreased. Moreover, by separating the three fractions according 
to size, Strandås et al. (2008a) showed that the 50% fraction contained 
smaller molecules than the 60% and 70% fractions. Thus, Strandås et al. 
(2008a) provide some support for the hypothesis of Struijs et al. (2009) in 
that the 50% methanolic fraction, which is most abundant in CoAG and 
FeAG, seems to contain the smallest molecules.   19 
1.1.2  Biosynthesis 
Lignans, hydroxycinnamic acids and flavonoids originate from the 
phenylpropanoid pathway where the amino acid phenylalanine is the 
precursor (Davin and Lewis, 2003; Lepiniec et al., 2006). The starting point 
of lignan biosynthesis is the deamination of phenylalanine by the enzyme 
phenylalanine ammonium lyase to yield cinnamic acid. Additional enzymatic 
steps yield e.g. p-coumaric acid, caffeic acid and ferulic acid. These phenolic 
acids can be converted into coenzyme-A activated forms which are reduced 
to aldehydes and finally alcohols, of which coniferyl alcohol is one example 
(Davin and Lewis, 2003). Two coniferyl alcohol radicals can be captured 
and coupled by a so-called dirigent protein to form the lignan pinoresinol 
(Davin  et al., 1997). The enzyme pinoresinol/lariciresinol reductase 
(Dinkova-Kostova  et al., 1996; Hano et al., 2006) then mediates its 
conversion into first lariciresinol and then SECO, which can be further 
converted to matairesinol by the enzyme secoisolariciresinol dehydrogenase 
(Xia  et al., 2001). The glucosylation of SECO to form SDG has been 
suggested to be mediated by the enzyme secoisolariciresinol 
glucosyltransferase (Ford et al., 2001) yet to be identified. Biosynthesis of the 
very diverse group of compounds that are collectively referred to as 
flavonoids starts with a reaction between coumaroyl-CoA deriving from the 
phenylpropanoid pathway and three malonoyl-CoA units deriving from the 
Krebs cycle (Lepiniec et al., 2006). 
By studying flaxseed at different developmental stages by stable and 
radioisotope precursor/tracer experiments, Ford et al. (2001) investigated the 
biosynthetic pathway of the flaxseed lignan oligomer. They concluded that 
the level of SDG in flaxseed increases during seed development and peaks at 
seed maturation. Since virtually no free SDG could be detected, it was 
assumed to be efficiently incorporated into the oligomeric structures once 
formed. CoAG and FeAG were found to be included into the oligomer at 
early stages of seed development. Coupling of SDG to HMGA was 
suggested to occur by coupling of glucose moieties with coenzyme A-
activated HMGA.  
1.1.3  Analysis of the phenolic compounds of the flaxseed lignan oligomer  
Following the discovery of SDG by Bakke and Klosterman (1956) and its 
connection to the enterolignans, several methods for the analysis of lignans 
and other phenolic constituents of the fat free portion of flaxseed have been 
developed. In order to obtain repeatable results, defatting of flaxseed cake 
prior to further treatment is crucial (Kozlowska et al., 1983; Harris and 
Haggerty, 1993).   20 
Extraction of the oligomeric material is usually carried out with solvents 
such as dioxane/ethanol, aqueous ethanol or methanol (Bakke and 
Klosterman, 1956; Westcott and Muir, 1996a; Struijs et al., 2009). 
Subcritical water extraction (Cacace and Mazza, 2006) and microwave-
assisted extraction (Zhang and Xu, 2007) have also been employed. To 
release free compounds, mainly in the form of glucosides, the oligomeric 
extract can be treated with alkali (Rickard et al., 1996; Westcott and Paton, 
2001; Cacace and Mazza, 2006; Struijs et al., 2009). The compounds may 
also be released from the oligomeric material as aglycones by enzymatic or 
acid hydrolysis (Obermeyer et al., 1995; Mazur et al., 1996; Liggins et al., 
2000; Charlet et al., 2002). Without prior extraction of the oligomeric 
material, direct alkaline hydrolysis in water and microwave-assisted 
extraction with alkali have been used (Eliasson et al., 2003; Beejmohun et al., 
2007).  
Extraction for analysis of the other phenolic compounds such as phenolic 
acids and flavonoids has been carried out in a similar manner as when 
analysing lignans, i.e. with organic solvents (Bakke and Klosterman, 1956; 
Oomah et al., 1995) or alcohols mixed with water (Kozlowska et al., 1983; 
Amarowicz et al., 1994; Oomah et al., 1996; Westcott and Muir, 1996a; 
Ford et al., 2001; Charlet et al., 2002; Degenhardt et al., 2002; Struijs et al., 
2009). The use of supercritical fluid (SCF) extraction has also been reported 
(Harris and Haggerty, 1993).  
SDG, phenolic acids and flavonoids absorb light in the UV-region. They 
have been quantified and determined by liquid and gas chromatography and 
mass spectroscopic and NMR techniques (Bambagiotti-Alberti et al., 1994; 
Mazur  et al., 1996; Westcott and Muir, 1996b; Chimichi et al., 1999; 
Westcott  et al., 2000; Willför et al., 2006; Struijs et al., 2007). In 
quantifications, the differences in efficiency of different modes of 
extractions, hydrolyses and the use of different flaxseed raw material have 
resulted in a broad variation in yields. A selection of quantitative results for 
SECO is shown in Table 2.  
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Due to varying methodologies, reports on quantities and types (e.g. free, 
ester-bound etc.) of phenolic acids in flaxseed are also diverging. Kozlowska 
et al. (1983) showed that the majority (59%) of phenolic acids in flaxseed 
were ester-bound. By extraction with 80% methanol, the content of ester-
bound phenolic acids in flaxseed was determined to be 320 mg/kg defatted 
flaxseed flour (DFF), the main constituents being p-hydroxybenzoic, trans-
ferulic and trans-p-coumaric acids. Free phenolic acids present at 220 mg/kg 
defatted flaxseed flour were mainly composed of trans- and cis-sinapic, p-
hydroxybenzoic, trans-p-coumaric and vanillic acids. The content of residual 
(non-extractable with the method used) phenolic acids was 70 mg/kg DFF. 
Dabrowski and Sosulski (1984) found no free phenolic acids when 
extracting DFF with tetrahydrofuran. Alkaline hydrolysis released 730 mg 
phenolic acids/kg DFF (89% of total phenolic acids, the major forms being 
trans-ferulic and trans-sinapic acid). Harris and Haggerty (1993) reported a 
content of approximately 11 mg ferulic acid/kg in whole flaxseed. They did 
not use alkaline hydrolysis and thus could not detect ester-bound phenolic 
acids. Oomah et al. (1995) reported a content of 8000-10 000 mg total 
phenolic acids/kg flaxseed, of which 48-66% were assigned to esterified 
phenolic acids. Phenolic acids that were not released after extraction and 
alkaline hydrolysis were assumed to be ether-bound. Eliasson et al. (2003) 
reported a p-coumaric acid glucoside content of 1200-8500 mg/kg flaxseed 
(dry weight) and a ferulic acid glucoside content of 1600-5000 mg/kg using 
direct alkaline hydrolysis. 
The mean total flavonoid content in flaxseed, measured by absorbance in 
80% methanolic extract at 404 nm, has been reported to be 490-870 mg/kg 
DFF (Oomah et al., 1996). Struijs et al. (2007) found 2000 mg/kg of HDG 
in flaxseed hulls, whereas Qui et al. (1999) only found 100 mg/kg in 
flaxseed.  
1.1.4  Metabolism and physiological effects 
In the early 1980s, the enterolignans enterodiol (ED) and enterolactone (EL) 
were identified as lignans of animal origin that differed from plant lignans in 
carrying phenolic hydroxyl groups only in the meta position of the aromatic 
rings (Figure 3). They were found in urine, plasma and bile as glucuronide 
and sulphate conjugates, and in unconjugated forms in faeces (Setchell et al., 
1979; Axelson and Setchell, 1980; Setchell et al., 1980; Axelson and 
Setchell, 1981; Setchell et al., 1981).  
   23 
 
Figure 3. Conversion of mammalian lignan precursors SDG and matairesinol to enterodiol 
and enterolactone by the gut microflora (adapted from Borriello et al., 1985). 
 
Later, SDG, matairesinol (Axelson et al. 1982), lariciresinol, pinoresinol 
(Heinonen et al., 2001) and lignin in plant cell walls (Begum et al., 2004) 
were identified as enterolignan precursors. Fibre-rich foods such as cereals, 
oilseeds, fruits and vegetables are rich sources of these precursors 
(Adlercreutz et al., 1982; Thompson et al., 1991; Mazur, 1998; Milder et al., 
2005) (Table 1). SDG/SECO results in both EL and ED formation, with 
varying reports on which product is dominant (Axleson et al., 1982; 
Saarinen et al., 2002; Smeds et al., 2004). Flaxseed supplementation has been 
reported to mainly increase ED concentration (Nesbitt et al., 1999). ED and 
EL are formed by oxidation of precursors in a dose-dependent manner by 
facultative anaerobic bacteria in the colon of animals and humans (Axelson 
and Setchell, 1981; Setchell et al. 1981; Borrielo et al. 1985; Rickard et al., 
1996; Clavel et al., 2006). Both the amount and the species composition of 
the bacteria seem to influence the production of enterolignans (Axelson and 
Setchell, 1981; Rowland et al., 1999; Clavel et al., 2005). The conversion 
has been shown to be enantiospecific (Saarinen et al., 2002; Jin et al., 2007a, 
b). Other factors that influence the bioavailability of enterolignans are 
precursor structure, intestinal transit time and time of exposure (Axelson et 
al., 1982; Saarinen et al., 2002; Smeds et al., 2004). The composition and the 
structure of the food may also play a role.  For example, enterolignan 
formation increased in vitro in xylanase-treated rye bran (Aura et al., 2005). 
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The absorption of enterolignan precursors from flaxseed has been shown to 
increase when the seeds are crushed or milled (Kuijsten et al., 2005). By in 
vitro fermentation with fresh human faecal inoculum, different flaxseed 
cultivars have been shown to produce different amounts of enterolignans 
(Thompson et al., 1991), probably due to variations in precursor content 
between cultivars, but possibly also due to structural differences between the 
flaxseeds or the lignan oligomers. Chemically unchanged lignans 
(matairesinol, lariciresinol, isolariciresinol, secoisolariciresinol) have been 
detected in low amounts in human urine. The cause may be precursor 
overload or insufficient bacterial capacity (Bannwart et al., 1989; Rickard et 
al., 1996).  
After absorption, ED and EL undergo enterohepatic circulation where 
glucuronic and sulphuric acid conjugates are formed in the liver, excreted in 
the bile, deconjugated by intestinal bacteria and then reabsorbed (Axelson 
and Setchell, 1980; Axelson and Setchell, 1981; Setchell et al., 1981). 
Conjugated ED and EL are transported in plasma to tissues such as the 
kidneys and uterus (Axelson and Setchell, 1981; Rickard and Thompson, 
1998). EL is normally the enterolignan found in the highest concentrations 
in blood and is also that most commonly examined in epidemiological 
studies (Setchell et al., 1980b; Nesbitt et al., 1999; Adlercreutz, 2007).  
Enterolignans and their precursors are similar to steroids in size and 
polarity, and are sterically similar to 17β-oestradiol (Figure 4) regarding the 
distance between the two -OH groups (Setchell et al., 1981; Tham et al., 
1998). Indeed, they have been shown to interact with oestrogen metabolism 
at different levels. In circulation, enterolignans and precursors compete with 
endogenous hormones in binding to sex hormone-binding globulin (SHBG) 
(Martin et al., 1996; Schöttner et al., 1997; Schöttner et al., 1998; Hillerns et 
al., 2005) and influence its biosynthesis (Adlercreutz et al., 1987). 
Enterolignans have also been shown to interfere with oestradiol biosynthesis 
by decreasing the activity of aromatase and 17β-hydroxysteroid 
dehydrogenase (Wang et al., 1994; Brooks and Thompson, 2005), which are 
the enzymes responsible for final conversion of steroid precursors to 
oestradiol. In addition, the enterolignans affect the activity of oestrogen 
receptors as observed as displacement of endogenous oestrogen, effects on 
gene transcription and cell proliferation (Mueller et al., 2004; Cosentino et 
al., 2007; Carreau et al., 2008) and in vivo effects on target tissues (Setchell et 
al., 1981; Waters and Knowler, 1982; Penttinen et al., 2007). Decreased 
formation and circulation of endogenous oestrogens limit stimulation of 
oestrogen-dependent tissues. A compound with weak oestrogenic effect can 
be anti-oestrogenic when competing with a compound that has a stronger   25 
oestrogenic effect. The effect is dependent on the dose, timing and duration 
of exposure (Tou et al., 1999). In a study by Mousavi and Adlercreutz 
(1992), oestradiol and enterolactone individually stimulated the growth of 
MCF-7 breast cancer cells in vitro, but together they inhibited each other’s 
effect. 
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Figure 4. Structure of 17β-oestradiol. 
The flaxseed lignans SDG/SECO and to some extent the enterolignans have 
been shown to possess antioxidant activities (Prasad, 1997b, 2000a; Kitts et 
al., 1999; Niemeyer and Metzler, 2003; Eklund et al., 2005; Hosseinian et 
al., 2006, 2007), which may protect body lipids from peroxidation. SDG has 
a lower antioxidant capacity than SECO (Hosseinian et al., 2007). 
Only one report on possible adverse health effects of flaxseed lignans 
could be found in the literature (Jacobs et al., 2005). EL and SECO were 
shown to activate the human pregnane X receptor (PXR), which mediates 
the induction of enzymes involved in steroid metabolism and xenobiotic 
detoxification. The authors suggest that this activation may possibly interfere 
with the action of the vast amount of pharmaceutical drugs that are 
cytochrome P4503A substrates.   
1.1.5  Health effects of mammalian and flaxseed lignans 
Breast cancer 
A reduced breast cancer risk has been reported for subjects with high urine 
and plasma levels of enterolignans (Ingram et al., 1997; Dai et al., 2002; 
Boccardo et al., 2004). Blood concentrations of EL above 16 nmol/L were 
associated with a reduced risk of breast cancer in a study with 366 cases and 
733 matched controls (Sonnestedt et al., 2008b). However, in several other 
studies no association between plasma enterolignan levels and a reduced risk 
of breast cancer could be established (den Tonkelaar et al., 2001; Kilkkinen 
et al., 2004; Ward et al., 2008). Recently, three meta-analyses on the 
relationship between breast cancer risk and plant lignan intake, enterolignan   26 
exposure and blood EL levels (Velentziz et al., 2009) showed little 
association between high plant lignan intake and a reduced cancer risk 
overall, but when the analysis was restricted to post-menopausal women a 
clear relationship was obtained. High enterolignan exposure was associated 
with a reduced breast cancer risk but blood EL levels were not. Conflicting 
results in human studies may depend on different biological properties of 
different tumour types or on too low concentrations of enterolignans in the 
populations studied (Sonnestedt et al., 2008b).  
Different results from studies on the protective effects of flaxseed lignans 
have also been reported. In an intervention study performed by Thompson 
et al. (2005), a daily intake of flaxseed for a month by 19 newly diagnosed 
postmenopausal breast cancer patients indicated protective effects of flaxseed 
lignans. Pure SDG when administered to rats at the early promotion stage of 
mammary tumourigenesis was shown to reduce the number of tumours. At 
the same time, urinary excretion of enterolignans was shown to increase 
significantly (Thompson et al., 1996b). The total volume of established and 
new mammary tumours was significantly decreased in rats that were fed 
SDG or flax. The effect was inversely related to urinary excretion of 
enterolignans (Thompson et al., 1996a). SDG also resulted in a reduction in 
the progression of mammary tumourigenesis in rats (Rickard et al., 1999), 
and pulmonary metastasis (Li et al., 1999) and distant metastasis, but not 
recurrence after surgical removal of tumours in mice (Chen et al., 2006). 
Apart from hormonal effects, the antioxidant properties of lignans have 
also been suggested to play a role in cancer protection (Prasad, 2000a). 
Protective effects of flaxseed against breast cancer that may not be attributed 
to lignans alone have also been observed. When SDG and flaxseed oil were 
administered together, they showed a synergistic protective effect (Chen et 
al., 2006), possibly related in part to the alpha-linolenic acid in the oil 
(Thiébaut et al., 2009). 
A high-fibre diet with its associated lignans seems to account for the 
cancer protective effects (Adlercreutz, 2007; Sonnestedt et al., 2008a) but the 
exact role of lignans is still unclear. The main theory seems to be that the 
lignans modulate the activity of endogenous oestrogen but it is possible that 
e.g. enterolignans are only markers for a healthy diet and that the true 
underlying mechanisms have not yet been discovered (Adlercreutz, 2007; 
Saarinen et al., 2007).  
Prostate cancer 
High levels of enterolactone in prostatic fluid have been suggested to 
indicate a lower risk of prostate cancer (Morton et al., 1997). A reduction in   27 
prostate tumour proliferation, prostate-specific antigen and total and free 
testosterone levels has been observed in patients with prostate cancer given a 
low-fat diet containing flaxseed (Demark-Wahnefried et al., 2001, 2004, 
2008).  
Inclusion of 5% flaxseed in the diet inhibited growth and development of 
prostatic carcinoma in mice, possibly due to hormonal effects of the flaxseed 
lignans (Lin et al., 2002). In male rats with experimental cancer, a 5% 
lifetime diet reduced prostate cell proliferation rate and prostate weight 
without a rise in sex hormone levels. A 10% lifetime diet, on the other 
hand, resulted in higher serum testosterone and oestradiol levels and prostate 
cell proliferation (Tou et al., 1999). EL and ED may also contribute to the 
protective effects, as indicated by an in vitro study where these lignans 
reduced the growth of three and two different prostate cancer cell lines, 
respectively (Lin et al., 2001). 
Colorectal cancer 
Dietary lignans have also been suggested to protect against colon cancer 
(Adlercreutz, 2002). However, studies on the effect of flaxseed lignans 
against colorectal cancer are sparse. Diets supplemented with flaxseed, flax 
meal or SDG showed a protective effect against colon cancer in rats in the 
long term (Jenab and Thompson, 1996). A reduction in early markers for 
colorectal cancer in rats fed flaxseed flour or flaxseed meal was also shown. 
The reduction was not linearly correlated to flaxseed intake (Serraino and 
Thompson, 1992). Induced colorectal cancer in multiple intestinal neoplasia 
(Min) mice was significantly reduced by flaxseed supplemented diets 
(Bommareddy et al., 2009). However, in other studies no effects of flaxseed 
or (-)-SECO were obtained in Min mice models (van Kranen et al., 2003; 
Oikarinen et al., 2005; Pajari et al., 2006). 
Cardiovascular disease 
Cardiovascular disease is a collective term for coronary heart disease (heart 
attacks), cerebrovascular disease, elevated blood pressure (hypertension), 
peripheral artery disease, rheumatic heart disease, congenital heart disease 
and heart failure (WHO, 2009a). Important risk factors for developing 
cardiovascular disease include diabetes, hypertension, smoking, obesity, high 
plasma cholesterol (hypercholesterolaemia), lack of physical activity and 
heredity (WHO, 2009b). Cardioprotective effects of flaxseed or 
enterolignans have been observed in humans and animals and may be due to 
inhibition of lipid peroxidation or changes in SHBG production, 
oestrogenic activity and circulation of cholesterol (Fahrat et al., 1996;   28 
Vanharanta et al., 1999; Chisolm and Steinberg, 2000; Vanharanta et al., 
2002; Lucas et al., 2004).  
High serum enterolactone concentrations have been correlated with a 
decreased level of in vivo lipid peroxidation (Vanharanta et al., 2002), and are 
also protective against acute coronary heart events in men as suggested by a 
case-control study (Vanharanta et al., 1999). In a prospective cohort study, 
men with elevated serum EL levels had a reduced risk of coronary heart or 
cardiovascular disease-related mortality (Vanharanta et al., 2003). The lignan 
phenolic complex did not affect plasma lipid concentrations, antioxidant 
capacity or endothelial function in healthy postmenopausal women (Hallund 
et al., 2006a, b). In hypercholesterolaemic subjects, however, a daily intake 
of the complex reduced plasma LDL and cholesterol levels by more than 
20% (Zhang et al., 2008). Flaxseed supplementation had a modest effect on 
plasma cholesterol levels in healthy menopausal women (Dodin et al., 2008).  
The phenolic complex, SDG and flaxseed low in alpha-linolenic acid 
(<3%) were shown to decrease the level of atherosclerotic lesions and 
plaques in hypercholesterolaemic rabbits (Prasad et al., 1998; Prasad, 1999, 
2005). Most experimental animal studies have shown a reduction in plasma 
cholesterol levels following consumption of flaxseed or SDG (Prasad et al., 
1998; Prasad, 1999, 2005; Lucas et al., 2004; Pellizzon et al., 2007). 
However, in a study by Prasad (1997a), the cholesterol levels in rabbits 
increased after consumption of flaxseed. Furthermore, SDG and its 
oligomer, when fed to rats, were shown to significantly increase the amount 
of cholesterol in the liver and liver lipids and to decrease the liver and 
plasma content of α- and γ-tocopherols in rats (Frank et al., 2004). 
Moreover, flaxseed was found to cause a significant reduction in α- and γ-
tocopherol levels in rats (Ratnayake et al., 1992). Reduced levels of vitamin 
E, γ-tocopherol in particular, have been associated with an increased risk of 
cardiovascular disease (Hensley et al., 2004). Other effects on lipid 
metabolism were shown in a study by Fukumitsu et al. (2008), where SDG 
and ED had beneficial effects on lipid metabolism in diet-induced fat 
accumulation in mice. Their findings suggest that the compounds regulate 
adipogenesis-related gene expressions by increasing the PPARγ DNA-
binding activity. PPARγ is a transcription factor (i.e. a protein that binds to 
specific DNA sequences and controls transcription) that is involved in 
regulation of adipogenesis, lipid and glucose metabolism (Rosen et al., 2000)  
Diabetes 
Diabetes is a chronic disease caused by deficiency in insulin production or 
by ineffectiveness of the insulin produced, resulting in increased blood   29 
glucose levels which cause damage to body systems, in particular the blood 
vessels and nerves (WHO, 2009c).  
Hypercholesterolaemic postmenopausal women showed reduced glucose 
and insulin levels after eating flaxseed (Lemay et al., 2002). In another group 
of hypercholesterolaemic subjects, the phenolic complex reduced the fasting 
plasma glucose levels (Zhang et al., 2008). In a study by Pan et al. (2007), 
hypercholesterolaemic postmenopausal women diagnosed with type II 
diabetes showed small improvements in long-term glycaemic control but no 
effect on fasting glucose or insulin sensitivity after eating low amounts of the 
phenolic complex for eight weeks. SDG has been demonstrated to prevent 
or delay the development of type I and II diabetes in diabetes-prone rats, 
probably by decreasing oxidative stress in body tissues (Prasad, 2000b, 2001).  
1.2  Flaxseed oil 
Among dietary plant oils, flaxseed oil has one of the highest contents of the 
essential omega-3 fatty acid alpha-linolenic acid (ALA), with amounts of 50-
60% (Velasco and Goffman, 2000; Hall et al., 2009). The second and third 
most dominant fatty acids in flaxseed oil are oleic acid and the essential 
omega-6 fatty acid linoleic acid (LA), with 11-29 and 9-21% respectively 
(Green and Marshall, 1981; Velasco and Goffman, 2000; Wakjira et al., 
2004; Choo et al., 2007). The oil content in the seed is in the range 22-47% 
(Velasco and Goffman, 2000; Eliasson et al., 2003; Wakjira et al., 2004). 
Both oil content and fatty acid composition depend on factors such as 
cultivar, location, environmental conditions and agricultural practices, the 
importance of which have been reviewed by Oomah and Kenaschuk (1995). 
Flaxseed lipids consist of more than 90% triacylglycerols, with the remaining 
part being free fatty acids, phospholipids, sterols and sterol esters (El 
Shattory, 1976).  
The unsaponifiable portion of flaxseed oil, mainly consisting of sterols 
and tocopherols, comprises about 0.4-1.4% of total lipids (Painter and 
Nesbitt, 1943; Choo et al., 2007). The main sterols are sitosterol, 
cycloartenol and campesterol, together making up 75% of total sterols 
(Schwartz et al., 2008). The total tocopherol content in flaxseed is 9.3-16.9 
mg/100 g seed (Oomah et al., 1997; Velasco and Goffman, 2000), with the 
major tocopherol being γ-tocopherol, which makes up 95-100% of total 
tocopherols (Oomah et al., 1997; Velasco and Goffman, 2000) and is present 
at levels of 11.2-52.0 mg/100 g oil (Choo et al., 2007; Schwartz et al., 
2008). Other tocopherols are α-tocopherol, with a content of 0.0-9.1 
mg/100 g oil (Choo et al., 2007; Schwartz et al., 2008) and δ-tocopherol at   30 
0.0-0.3 mg/100 g seed (Oomah et al., 1997; Velasco and Goffman, 2000) or 
0.95 mg/100 g oil (Schwartz et al., 2008). The tocopherol content is mainly 
influenced by cultivar but also by location and year (Oomah et al., 1997). 
Other minor constituents that have been identified in flaxseed oil include 
the tocopherol analogue plastochromanol-8 (Velasco and Goffman, 2000), 
the carotenoids β-carotene, lutein and violaxanthin (Pretova and Vojtekova, 
1985), squalene and aliphatic hydrocarbons (Herchi et al., 2009) and geranyl 
geraniol (Fedeli et al., 1966). Flaxseed oil has also been found to contain 
768-3073 mg/kg of total phenolic acids and 127-256 mg/kg of total 
flavonoids (Choo et al., 2007).  
Apart from agroclimatic conditions, the composition of vegetable oils also 
depends on the extraction procedure and the treatment of the oil. A refined 
oil is the result of treating a crude oil by a multiple-step procedure often 
including e.g. filtration, degumming, neutralisation, bleaching, deodorisation 
and winterisation (Karlshamns AB, 1989). These procedures rid the oil of 
e.g. solid particles, phospholipids, proteins, carbohydrates, free fatty acids, 
waxes and compounds giving unwanted taste and odour and also prolong 
the shelf-life of the oil. However, the procedures may also decrease the 
amount of desirable minor compounds present (Kamal-Eldin, 2005). The 
so-called virgin or cold-pressed oils are extracted under milder conditions, 
purified by filtration or settling and not subjected to other refining steps 
(Moreau and Kamal-Eldin, 2009).  
Minor compounds of vegetable oils, especially tocopherols, phytosterols 
and phenolic compounds such as those found in olive oil and the lignans in 
sesame oil, have attracted increased attention lately due to their biological 
and physiological effects and their potential ability to improve human health 
(Kamal-Eldin, 2005). 
1.2.1  Significance of omega-3 fatty acids for health 
The omega-3 (n-3) fatty acid ALA (18:3 n-3) and the omega-6 (n-6) fatty 
acid LA (18:2 n-6) (Figure 5) are essential fatty acids in that they are needed 
to maintain health (Burr and Burr, 1930) but cannot be synthesised from any 
dietary precursors by humans so they have to be present in the diet. As 
components of cell membranes, n-3 and n-6 fatty acids increase membrane 
fluidity and play an important role for the function of cell membranes and 
the nervous system (Davis and Kris-Etherton, 2003). When naming fatty 
acids, the number to the left of the colon signifies the number of carbon 
atoms and the number to the right the degree of unsaturation, i.e. the 
number of double bonds in the carbon chain. The omega-3 and omega-6 
(or n-3 and n-6) numbers describe the position of the first double bond   31 
counting from the methyl end of the chain. ALA and LA can be elongated 
(i.e. chain length increases) and desaturated (i.e. the number of double bonds 
increases) to longer-chain n-3 and n-6 fatty acids, respectively, by a series of 
enzymatic reactions that take place in the endoplasmic reticulum and the 
peroxisomes (Figure 6). Double bonds are inserted by enzymes called 
desaturases. The position of insertion is counted from the carboxyl end of 
the chain and is given a delta number (Δ= delta). Higher animals lack the 
ability to insert double bonds beyond Δ9. Chain length is increased by 
enzymes called elongases. The most important products of these elongation 
and desaturation reactions are the highly unsaturated fatty acids (HUFA; 
chain length ≥20 carbons and ≥3 double bonds) eicosapentaenoic acid 
(EPA), docosahexaenoic acid (DHA) and arachidonic acid (AA). 
 
 
 
 
Figure 5. Chemical structure of the essential fatty acids alpha-linolenic acid (18:3 n-3; above), 
and linoleic acid (18:2 n-6; below).   
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Figure 6. The metabolic pathway of omega-3 (n-3) and omega-6 (n-6) fatty acids. Adapted 
from Voss et al., 1991. 
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EPA and AA are substrates for the production of hormone-like compounds 
called eicosanoids. The eicosanoids from EPA have weak activity and inhibit 
inflammation, while eicosanoids from AA have strong activity that promotes 
inflammation (Harper and Jacobson, 2001). Excessive action of eicosanoids 
from the n-6 fatty acid AA is associated with health disorders such as 
coronary heart disease (Lands, 2001). On the other hand, there is strong 
epidemiological evidence that consumption of oils rich in n-3 fatty acids 
such as ALA, EPA and DHA lowers the incidence of coronary heart disease 
(Dyerberg et al., 1978; de Lorgeril et al., 1994; Lanzmann-Petithory, 2001; 
Harper and Jacobson, 2001).  
At present, the Swedish National Food Administration recommends an 
intake of 5-10% energy of polyunsaturated fatty acids per day, of which 1 %-
unit should be n-3 fatty acids (Livsmedelsverket, 2009). Not only a specific 
dietary intake of n-3 fatty acids but also the balance between n-3 and n-6 
fatty acids may be important (Lanzmann-Petithory, 2001; Simopoulos, 
2008). The elongation and desaturation of ALA and LA involve the same 
enzymes (Figure 6), so the intake of LA may affect the conversion of ALA 
into longer-chain metabolites and vice versa (Simopoulos, 2008). In an 
evolutionary perspective, the n-6 fatty acids in our diet have increased 
recently due to extensive use of vegetable oils with very high LA/ALA 
ratios in food manufacturing and also because farm animals are fed diets high 
in LA, leading to meat that is ‘enriched’ in n-6 fatty acids (Simopoulos, 
1991; Wood and Enser, 1997; Nilzen et al., 2001; Eriksson and Pickova, 
2007).   
Dietary sources with high ALA/LA ratios include flaxseed, perilla and 
camelina oil, and walnuts (Harper and Jacobson, 2001; Hall et al., 2009). 
Apart from being formed in the body by elongation and desaturation of 
ALA, n-3 HUFA can also be ingested through food. Fish is an important 
source of n-3 HUFA.  
1.2.2  Flaxseed oil as an ingredient in fish feed 
Long chain n-3 fatty acids such as EPA, DPA and DHA are readily available 
in fish oil, which is a common lipid ingredient in commercial fish feed. 
Lipids in tissues reflect the lipid content in the diet (Sargent, 2002) and the 
presence of n-3 HUFA in feed also results in fish flesh with high relative 
amounts of these fatty acids, which are beneficial for human consumers. 
However, fish oil resources for fish feed are becoming scarce, so alternative 
lipid sources must be found (FAO, 2002). For this reason, partial or   34 
complete substitution of fish oil with vegetable oils in fish feed is being 
assessed. 
Salmonids, e.g. Atlantic salmon (Salmo salar), have some ability to convert 
ALA and LA, present in high concentrations in many vegetable oils, to 
long-chain HUFA (Sargent, 2002). Flaxseed oil contains high levels of n-3 
desaturation/elongation precursors in the form of ALA, so it should be a 
good candidate for fish oil substitution in fish feeds (Tocher et al., 2002). 
Numerous studies on Atlantic salmon and rainbow trout (Oncorhynchus 
mykiss) have shown that feed containing flaxseed oil does not have any 
negative effects on fish growth (Bell et al., 1997, 2003, 2004; Tocher et al., 
2000; Menoyo et al., 2005). However, despite observed increased 
desaturation and elongation activities (Bell et al., 1997; Tocher et al., 2002), 
flaxseed oil diets and other vegetable oil diets have failed to maintain the n-3 
HUFA levels in fish tissues (Thomassen and Røsjø, 1989; Tocher et al., 
2000; Bell et al., 2003; Menoyo et al., 2005; Chen et al., 2006).  
The sesame seed lignan sesamin (Figure 1c) has been shown to increase 
the relative amount of DHA in white muscle of rainbow trout fed a diet 
with fish oil completely replaced with vegetable oils (Trattner et al., 2008). 
A combination of flaxseed oil and sesamin led to lower production of DHA 
than a 6:4 (v/v) mixture of flaxseed oil and sunflower oil and sesamin in 
rainbow trout. The fact that sesamin added to the mixed oil resulted in 
higher levels of DHA compared with sesamin added to flaxseed oil was 
surprising, since flaxseed oil contains more ALA than the mixed oil and thus 
more substrate for DHA formation. The negative effect of flaxseed oil on n-
3 HUFA formation has been proposed to be caused by the high ALA/LA 
ratio in flaxseed oil (Tocher et al., 2002). However, the effect might also be 
attributable to minor components present in the flaxseed oil (Kamal-Eldin, 
2005) possibly interfering with the desaturation and elongation of ALA or 
with other steps in lipid uptake and metabolism. 
Even though flaxseed oil has so far not been proven to maintain the 
levels of n-3 HUFA in fish flesh, it may still have an advantage over other 
vegetable oils in that it results in fish flesh with a high ALA content and thus 
a high total n-3 fatty acid content (Menoyo et al., 2005; Chen et al., 2006). 
The effects of different diets on the lipid composition of fish may differ in 
different fish species, in fish at different developmental stages and in 
anadromous fish such as salmon and trout due to e.g. fresh/salt water transfer 
(Bell et al., 1997; Tocher et al., 2000; Sargent, 2002; Zheng et al., 2005). 
There is also a large individual variation in the ability of fish to maintain 
high levels of n-3 HUFA in their flesh (Schlechtriem et al., 2007).    35 
2  Objectives 
 
The specific aims of this thesis were: 
 
To develop an HPLC method for the quantification of SDG in flaxseed 
(Paper I). 
 
To identify two major peaks that elute before SDG in the HPLC 
chromatograms from the method developed in Paper I, and to obtain 
preliminary information on the flaxseed lignan oligomer by 
chromatographic and spectroscopic analyses (Paper II). 
 
To elucidate the structure of the flaxseed lignan oligomer by 
chromatographic and spectroscopic analyses (Paper III). 
 
To test the hypothesis that higher SDG to hydroxycinnamic acid ratio in 
flaxseed is associated with smaller lignan oligomer size (Paper IV). 
 
To test the effect of purified flaxseed triacylglycerols and sesamin on the 
fatty acid composition in white muscle of rainbow trout (Paper V).   36 
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3  Analytical procedures 
3.1  Work related to the lignan oligomer of flaxseed (Papers I-IV) 
An outline of the work resulting in Papers I-III is shown in Figure 7. For 
more detailed descriptions of the procedures presented below, see Papers I-
IV.  
In Paper I, SDG was purified from a flaxseed extract by reversed and 
normal phase column chromatography for use as an external standard in 
quantifications and for future reference. The identity and purity of the 
isolated SDG were determined by proton nuclear magnetic resonance (
1H 
NMR). A high performance liquid chromatography (HPLC) method for the 
quantitative determination of SDG in flaxseed was developed and used for 
analysis of SDG in Swedish (n = 14) and Danish (n = 15) flaxseed cultivars. 
SDG was detected by ultra violet-diode array detection (UV-DAD) and its 
content in flaxseed was calculated with the help of a standard curve 
produced using the purified SDG at the concentrations 0, 20, 40, 80, 120 
and 160 µg/mL (y = 3.69x – 9.21; R
2 = 0.999).  
In Paper II, an unhydrolysed oligomeric flaxseed extract (referred to in 
the paper as the whole polymer) was fractionated with 0-100% methanol in 
10 %-unit intervals on a C18 reversed phase solid phase extraction (SPE) 
column yielding 11 fractions. These fractions were analysed by HPLC. The 
main UV-absorbing fractions, shown to be eluted with 50, 60 and 70 % 
aqueous methanol, and the whole extract were analysed by one- and two-
dimensional NMR techniques (
1H NMR, COSY, HSQC-DEPT and 
HMBC) to obtain structural information on the oligomer. The same 
oligomeric fractions were also subjected to alkaline hydrolysis and analysed 
by HPLC.  
   38 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Overview of analytical procedures and outcomes of Papers I-III.   39 
SDG was identified by comparison with a standard (Paper I) and preliminary 
information on the two other major peaks in the chromatograms was 
obtained by LC-MS and NMR. The compounds representing the two 
HPLC-peaks were isolated from an aqueous SPE fraction by normal phase 
column chromatography and identified by NMR. The sugar content and 
the yield of the whole extract were determined by qualitative sugar analysis 
(Theander et al., 1995) and gravimetrical determination, respectively. 
In Paper III, the major fraction of the oligomeric extract was obtained by 
washing the whole extract on a SPE column with 50% aqueous methanol 
followed by elution with 60% methanol. To elucidate the structure of the 
SDG-complex, the fraction was analysed by different NMR techniques (
1H 
NMR, 
13C NMR, TOCSY, HSQC-DEPT and HMBC). Standard SDG 
(see above) and HMGA were used as reference compounds. 
In Paper IV, further insights were sought into the properties of the lignan 
oligomer. Seeds from seven flax cultivars (Agraf 17, Biltstar, Early Bird, 
Niagara, Talon, Taurus, Vimy) with different ratios of SDG to CoAG and 
FeAG (Westcott and Paton, 2001; Eliasson et al., 2003) were used. 
Oligomeric extracts were obtained by extracting DFF according to Struijs et 
al. (2007) and the extracts were purified by reversed phase C18 SPE. The 
yields of the oligomeric extracts were determined gravimetrically. The 
extracts were analysed by reversed phase ultra-high performance liquid 
chromatography (UHPLC) and gel permeation chromatography (GPC) 
using the same columns and conditions as in Struijs et al. (2007). 
For quantification of CoAG, FeAG, HDG and SDG, the oligomeric 
extracts were subjected to alkaline hydrolysis with 75 mM sodium 
hydroxide according to Struijs et al. (2009). Hydrolysed samples were 
purified by SPE. Samples were analysed by UHPLC-MS and 
chromatographic peaks were assigned by comparison with their mass spectra. 
The amounts of CoAG, FeAG, HDG and (+)-SDG and (-)-SDG in the 
extracts were determined with reference to standards. 
Finally, fractions of the unhydrolysed lignan oligomeric extracts eluted 
from SPE columns with 50, 60 and 70 % aq. methanol were collected. The 
percentage contribution of each fraction to their combined yield was 
determined gravimetrically. Combined fractions were analysed by matrix 
assisted laser desorption/ionisation time of flight mass spectrometry 
(MALDI-TOF MS).   40 
3.2  Work related to flaxseed oil (Paper V) 
A feeding trial was conducted in which rainbow trout (Oncorhynchus mykiss) 
were fed six experimental diets containing purified flaxseed triacylglycerols, 
unaltered flaxseed oil or a mixed oil (sunflower oil/flaxseed oil), with and 
without the addition of the sesame lignan sesamin. The analytical procedures 
undertaken are summarised below. For further details see Paper V. 
3.2.1  Feed preparation 
By essentially following the method of Fuster et al. (1998), a commercial 
refined food-grade flaxseed oil was purified by adsorption chromatography, 
to obtain a purified flaxseed oil (PFSO) that was composed mainly of 
triacylglycerols (TAGs). Different batches of unaltered flaxseed oil (FSO) 
were mixed in order to obtain a α-linolenic (ALA) and linoleic acid (LA) 
composition that was comparable to that in the PFSO. (+)-γ-tocopherol and 
(+)-α-tocopherol were added to the PFSO and the FSO to make their 
tocopherol levels comparable. Among other ingredients, diets were prepared 
to contain 22% defatted fish meal and 22% vegetable oil. Sesamin (98% 
purity) was added at 0.58 g 100
-1 g feed according to Trattner et al. (2008). 
The six diets used were: Flaxseed oil (FSO), flaxseed oil with added sesamin 
(FSO+S), purified flaxseed oil (PFSO), purified flaxseed oil with sesamin 
(PFSO+S), flaxseed and sunflower oil mixed 6:4 v/v (MO), and the mixed 
oil with sesamin (MO+S). 
3.2.2   Fish 
A total of 114 juvenile rainbow trout from northern Sweden were divided 
into six groups and each group was fed one of the six experimental diets (see 
above) ad libitum for 58 days. At harvest, the fish were dissected and then 
kept at -80 °C until further analysis. Only fish that had eaten the feed and 
that had at least doubled their weight were analysed for fatty acid 
composition and tocopherol and sesamin levels. 
3.2.3  Lipid extraction and determination of fatty acids 
Lipids from white muscle and diets were extracted following the method of 
Hara and Radin (1978). For fatty acid analysis, total lipids of fish white 
muscle were separated into TAG and PL according to Pickova et al. (1997). 
The total lipids from the diets and TAG and PL from white muscle were 
methylated according to Appelqvist (1968) and analysed by GC using the 
same column and conditions as in Trattner et al. (2008).    41 
3.2.4  Sesamin and tocopherol determinations 
For the analysis of sesamin and α- and γ-tocopherols in oils, feed and fish 
white muscle, lipids were dissolved in hexane and analysed by HPLC using 
the same system, column and conditions as described by Moazzami and 
Kamal-Eldin (2006). The concentrations of α- and γ-tocopherol and 
sesamin were determined by reference to authentic standards.   42 
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4  Results and discussion 
4.1  Work related to the lignan oligomer of flaxseed (Papers I-IV) 
In 1998, at the beginning of this work, the nature of the extractable 
phenolic polymeric material first described by Klosterman and Smith (1954) 
was not known. Moreover, reports on the SDG/SECO content in flaxseed 
showed great variation (Table 2), and values were often surprisingly low 
considering the high amounts of mammalian lignans excreted in urine of 
humans and animals after flaxseed ingestion (Axelson et al., 1982; Thompson 
et al., 1991). Our aim was thus to develop a quantitative method for the 
analysis of SDG in flaxseed and to learn more about the ‘complex’ in which 
SDG is included. This work is described in detail in Papers I-IV (see 
Appendix) and is summarised below. 
4.1.1  Method development 
In Paper I, defatted flaxseed flour (DFF) was extracted with 1,4-
dioxane/95% ethanol (1:1, v/v) and hydrolysed in methanolic base 
according to Bakke and Klosterman (1956). Upon repeated HPLC analyses, 
it was discovered that the first two peaks (later assigned to p-coumaric acid 
and ferulic acid glucosides, see below) were diminished and some extra 
peaks eluted later, close to the SDG peak. When hydrolysis was carried out 
with aqueous base instead, the two peaks remained stable, suggesting 
formation of less polar derivatives due to transesterification of carboxylic 
groups in the methanolic system. The yield of SDG was unaffected by the 
method of hydrolysis, but the separation of HPLC peaks around the SDG 
peak was better when hydrolysis was performed in water. Thus, aqueous 
base hydrolysis was chosen for further work.    44 
 
Figure 8. Typical chromatogram of a base-hydrolysed extract from flaxseed. 
 
Figure 8 presents a typical HPLC chromatogram of the base-hydrolysed 
extract from flaxseed. The HPLC gradient developed in this study provided 
very good separation for SDG and easier interpretation of its UV-DAD and 
LC-MS spectra. 
The method developed was used to study the variation in SDG content 
in flaxseed cultivars grown in Sweden (n = 14) and Denmark (n = 15). The 
level of SDG in these 29 samples varied between 11700 and 24100 mg/kg 
in DFF and between 6100 and 13300 mg/kg in whole seeds. These levels 
are in agreement with those reported by Rickard et al. (1996), Westcott and 
Muir (1996b), Liggins et al. (2000) and Charlet et al. (2002) (Table 2; yields 
reported as SECO). Eliasson et al. (2003) analysed 27 different cultivars with 
direct alkaline hydrolysis and reported an approximately two-fold higher 
mean SDG yield than was observed using the method developed in the 
present study (Table 2). The difference may be due to the efficiency of the 
analytical procedure, but may also be due to differences between years, 
cultivars or growing locations. Westcott and Muir (1996b) found a two-fold 
variation in flaxseed lignan concentration to be mainly due to cultivation 
year, with flax variety of secondary importance and cultivation location of 
less importance. 
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4.1.2  Isolation and structural determination of p-coumaric and ferulic acid 
glucoside 
In Paper II, LC-MS of the first two peaks in the chromatograms of the 
hydrolysed oligomeric extract from the HPLC method developed (see 
above) (at 12.8 and 14.6 min; Figure 8) showed ions corresponding to 4-O-
β-D-glucopyranosyl-p-coumaric acid and 4-O-β-D-glucopyranosyl-ferulic 
acid. The structures of these compounds were determined by NMR and 
were found to be in accordance with NMR data presented by Luyengi et al. 
(1993) and Westcott et al. (2000) for 4-O-β-D-glucopyranosyl-p-coumaric 
acid and 4-O-β-D-glucopyranosyl-ferulic acid, respectively. 
4.1.3  Structural analyses of the lignan oligomer 
Paper II also sought insights into the structure of the flaxseed oligomer 
(called polymer in that paper). The yield of the oligomeric extract from DFF 
was 2.9% as determined gravimetrically. Sugar analysis showed that the only 
sugar residue present in the extract was glucose. Three fractions of the 
whole extract were obtained by eluting an SPE-column with 50, 60 and 70 
% aqueous methanol. Figure 9 shows HPLC chromatograms of the whole 
extract and the three fractions. The broad peaks were transformed to sharp 
peaks upon hydrolysis (Figure 8). Thus, the broad nature of the 
unhydrolysed peaks suggested a variation in e.g. molecular weight, 
substituent and/or substitution pattern. On the basis of peak area, the 60% 
fraction was the largest fraction (approx. 64%), followed by the 50% fraction 
(approx. 23%) and the 70% fraction (approx. 13%). The whole extract and 
its three fractions were similar with regard to the nature of their components 
absorbing in the UV range used for detection (210-400 nm). However, the 
relative ratios of the components of the three oligomeric fractions differed. 
The HPLC chromatogram of the hydrolysed 60% fraction, the major part of 
the oligomeric extract, was most similar to that of the whole extract. The 
70% fraction was rather similar to the 60% fraction but had a slightly higher 
proportion of SDG compared with other components. The 50% fraction, on 
the other hand, was clearly different in containing a much smaller 
proportion of SDG and a much higher proportion of the p-coumaric and 
ferulic acid glucosides. It was possible to observe the same structural 
variations by 
1H NMR analysis. Similar results regarding the relative size and 
composition of the three fractions were obtained by Strandås et al. (2008a). 
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Figure 9. Chromatogram of an unhydrolysed oligomeric flaxseed extract (whole extract) and 
three fractions obtained by eluting an SPE column with 50, 60 and 70 % aqueous methanol. 
 
Paper III further investigated the structure of the oligomers by performing 
additional NMR-analyses on the 60% methanolic fraction from SPE of the 
whole extract. 
1H NMR analysis revealed signals corresponding to SDG and 
probably CoAG and FeAG, as well as the CH3 and CH2 groups of 3-
hydroxy-3-methylglutaric acid (HMGA; Figure 2). 
13C NMR showed peaks 
for SDG and HMGA residues but no visible peaks for the other phenols 
(mainly CoAG and FeAG). The carboxylic carbon signal assigned to 
HMGA was 2 ppm upfield from that of the free HMGA, indicating that 
HMGA is esterified in symmetrical structures. HSQC-DEPT revealed two 
types of strong cross peaks, showing that the C-6 of glucose in SDG (Figure 
2) was present in both non-esterified and ester-linked forms (Farah et al., 
1992). Since some C-6 of the glucose residues in SDG were ester-linked 
and some were not, some glucose residues must be in terminal position in 
the oligomer. This finding was confirmed by TOCSY, which showed two 
types of spin systems for the protons at positions 7, 8 and 9, where signals 
from the linked SDG were downfield from those of terminal SDG. HMBC 
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revealed that the ester link is between the carboxylic carbon of HMGA and 
some of the C-6 of glucose. Taken together, these results suggested a linear 
and symmetrical structure composed of SDG and HMGA units. 
The structure of the oligomer was elucidated from two types of 
calculations: 1) the ratio of terminal versus linked glucose residues in the 
oligomer; and 2) the ratio between SDG and HMGA units. The ratio of 
terminal versus intermediate SDG groups was roughly calculated as 1:4 from 
the 
13C NMR spectrum by integration of the peaks of terminal and linked 
glucose. Integration of peaks in the 
1H NMR spectrum, two protons at 
positions 8 and four protons at positions 7 of SDG and the –CH2- groups of 
HMGA gave an SDG/HMGA ratio of 0.56/0.44. The average numbers of 
SDG and HMGA molecules in this oligomer were calculated as 4.67 and 
3.67, respectively. Both calculations support an average structure of approx. 
4000 Da, containing two terminal and eight linked glucose residues (Figure 
10). These results are in line with those of Ford et al. (2001) which suggest a 
family of SDG-HMGA dimers, trimers, tetramers and so forth to be present 
in mature flaxseeds. The work presented in Paper III was the first to reveal 
the structure of SDG oligomers in flaxseed. 
 
 
 
 
Figure 10. The structure of the flaxseed lignan oligomer (average size, n = 3). 
4.1.4  Further insights into the nature of the flaxseed lignan oligomer 
It was shown recently that the flavonoid herbacetin diglucoside (HDG) is 
part of the oligomeric structure (Struijs et al., 2007). In addition, as 
evidenced by NMR analyses, the hydroxycinnamic acids CoAG and FeAG 
are incorporated into the oligomer directly ester-linked to the C-6 of the 
glucose units of SDG (Struijs et al., 2008) (Figure 2). Since the linking 
molecule HMGA also binds to the C-6 position of the glucose moieties 
(Ford  et al., 2001; Struijs et al., 2008; Paper III), the binding of the   48 
hydroxycinnamic acids to this site blocks further growth of the oligomer in 
that direction. Struijs et al. (2009) therefore proposed that the incorporation 
of CoAG and FeAG determines the size of the oligomer. All previous 
studies on flaxseed lignan oligomers have been performed using a single 
cultivar (Ford et al., 2001; Strandås et al., 2008a; Struijs et al., 2009) and thus 
Paper IV aimed at testing the size determination hypothesis of Struijs et al. 
(2009) by comparing seven different flaxseed cultivars with different SDG to 
hydroxycinnamic acid ratios. 
The molar contributions of SDG, CoAG, FeAG and HDG and the molar 
ratios of SDG to hydroxycinnamic acids in DFF, as determined by UHPLC 
analysis of base-hydrolysed extracts, are shown in Table 3. Results from 
UHPLC analyses of the unhydrolysed oligomers from the different cultivars 
showed a slight gradual change towards narrower and later eluting peaks as 
the ratio of SDG to CoAG increased. The results suggest that the oligomeric 
polarity and molecular size distribution in the different flaxseeds decreases 
with an increased ratio of SDG to CoAG. GPC of the unhydrolysed 
oligomer supported the slight gradual change towards higher molecular size 
with an increasing ratio of SDG and CoAG.  
By fractionating the lignan oligomer of flaxseed according to polarity 
using solid phase extraction with 50, 60 and 70 % aqueous methanol, it was 
shown that the majority of the oligomeric extract ended up in the 60% 
methanolic fraction (Table 4), in accordance with previous results (Strandås 
et al., 2008a; Paper II). Separation of the oligomeric extracts according to 
polarity and size showed that the 50% fraction contained the smallest 
molecules and had the highest proportion of hydroxycinnamic acids of the 
three fractions (Strandås et al., 2008a). Thus, the decreasing yield of the 50% 
fraction with increasing SDG/CoAG (Table 4) provides further evidence 
that cultivars with high SDG to hydroxycinnamic acid ratio contain 
oligomers with lower polarity and higher molecular weight. 
MALDI-TOF MS analyses of the seven cultivars did not show a gradual 
increase in molecular size with increased SDG/CoAG ratio, but they 
suggested that Vimy, the cultivar having the largest SDG to 
hydroxycinnamic acid ratio, had a higher average mass range than the other 
six cultivars, which were similar to each other (Figure 11).    49 
 
Table 3. Molar composition of the lignan oligomer from different flaxseed cultivars 
Cultivar Molar 
composition, % 
     Molar  ratio   
 CoAG  FeAG  HDG  SDG    SDG/CoAG  SDG/HCA 
Early Bird  43  20  4  33      0.8    0.5 
Taurus 35  18  4  43      1.2    0.8 
Biltstar 23  23  4  50      2.2    1.1 
Agraf 17  21  15  5  59      2.8    1.6 
Talon 21  12  4  63      3.0    1.9 
Niagara 13  24  6  58      4.5    1.6 
Vimy 3  8  6  83      27.7    7.5 
CoAG = p-coumaric acid glucoside, FeAG = ferulic acid glucoside, HDG  = herbacetin 
diglucoside, SDG = secoisolariciresinol diglucoside, HCA = hydroxycinnamic acids (i.e. 
CoAG and FeAG) 
 
 
Table 4. Percentage yield of the unhydrolysed flaxseed lignan oligomeric extract after fractionation by 
C18 solid phase extraction (SPE) with 50, 60 and 70 % aqueous methanol (MeOH). See also Table 
3 for SDG to hydroxycinnamic acid ratios 
Cultivar    % yield per methanolic fraction 
 50% 
MeOH 
60% 
MeOH 
70% 
MeOH 
Early Bird  25  65  10 
Taurus 15  75  10 
Biltstar 16  73  11 
Agraf 17  12  79  9 
Talon 11  70  19 
Niagara 11  70  19 
Vimy 4  76  20 
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Figure 11. Molecular mass distribution (Da) as a percentage of total peak area from MALDI-
TOF MS analyses of the unhydrolysed oligomeric extracts of seven different flaxseed 
cultivars. 
Assuming that all CoAG and FeAG are linked with SDG in oligomeric 
structures, cv. Vimy should be at least 5458 Da (7.5 SDG + CoAG) (Table 
3) which is near the average molecular weight of 4000 Da estimated for 
another flaxseed sample in Paper III (see above). The range of molecular 
masses of the oligomers in the other cultivars would then be between 995-
1360 Da (min. SDG + CoAG = 994.9 Da to max. SDG + 2 FeAG = 
1363.1 Da). This supports in part the MALDI-TOF results obtained for 
these cultivars in this study, as most peaks in their spectra were below 1500 
Da. However, looking at Table 4, where all cultivars have at least 75% of 
their phenolic compounds in the 60% plus 70% methanolic fractions, and 
considering the molar composition in Table 2 and the results of Strandås et 
al. (2008a) (see above), it is clear that all hydroxycinnamic acids cannot be 
bound to C-6 of the glucose units in oligomers containing SDG. It is 
therefore suggested that there may exist different types of SDG oligomers, 
e.g. those end-capped by hydroxycinnamic acids at both ends, those end-
capped at one end and those not carrying hydroxycinnamic acids at all. In 
fact, there is NMR evidence that SDG is not always end-capped (Paper III). 
Some oligomers, of low abundance, may possibly carry glucosylated 
hydroxycinnamic acids at -OH groups of the glucose units other than C-6. 
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It is also possible that CoAG and FeAG are involved in other structures than 
SDG oligomers. 
The results suggest that depending on the proportion of monomeric 
constituents in the seeds, different flaxseeds contain different populations of 
oligomers, those with high proportions of hydroxycinnamic acids and those 
with high proportions of SDG. Hydroxycinnamic acids are formed and 
disappear into bound forms at early stages of seed development, while SDG 
is formed and bound at later stages (Ford et al., 2001). If the 
hydroxycinnamic acids terminate the elongation of the oligomer, small 
oligomers will be formed in early stages of seed development when the 
content of free hydroxycinnamic acids is high. Larger oligomers with 
relatively more SDG will be formed in later stages of seed maturation 
(Struijs et al., 2009 
The mass numbers for the two major peaks in cv. Vimy were 709 and 
2000 Da. The mass of the major peak in the other six cultivars was 907 Da. 
These peaks and a few others have not been successfully assigned to any 
oligomeric structures, suggesting that they originate from compounds that 
are not part of the oligomeric structure. The MALDI-TOF spectrum 
obtained from an unhydrolysed extract of flaxseed hulls that was presented 
by Struijs et al. (2009) differed from the spectra obtained from unhydrolysed 
extracts of DFF in Paper IV in that it seemed to display a higher resolution 
and higher signal to noise levels. The MALDI-TOF spectra in this study 
seemed to have been obscured by the presence of interfering compounds to 
a higher extent, which made it difficult to obtain good signals for the 
oligomeric constituents. 
4.2  Work related to flaxseed oil (Paper V) 
4.2.1  Fish white muscle lipid composition 
When comparing the TAG fraction of the white muscle of fish fed the 
FSO+S diet with fish fed the FSO diet, there was a significant decrease in 
ALA and slight (non-significant) increases in EPA and DHA and the   
desaturation index (i.e. the measure of the conversion ALA to longer and/or 
more desaturated products) n-3HUFA/ALA. The PFSO and PFSO+S diets 
gave opposite effects to the FSO and FSO+S diets, respectively. We 
checked the possibility that treatments were switched during feeding, but 
this possibility was dismissed since sesamin was only found in muscles of fish 
that were intended to be fed sesamin. The MO+S diet resulted in slight 
(non-significant) increases in EPA and DHA compared with the MO diet   52 
(Table 3 in Paper V). In the PL fraction, there were no clear effects of the 
FSO/FSO+S and PFSO/PFSO+S diets on ALA and DHA, but again, 
PFSO and PFSO+S consistently behaved in the opposite way to FSO and 
FSO+S, respectively. The MO+S diet resulted in a significant increase in 
DHA and DHA/ALA compared with the MO diet (Table 3 in Paper V).  
The effects of the FSO+S diet on the fatty acid composition of the white 
muscle TAG fraction that were observed in Paper V are supported by similar 
observations in the study of Trattner et al. (2008). The effects for TAGs in 
the MO/MO+S treatments were similar in the two studies but the overall 
effects were more pronounced in Trattner et al. (2008). Possible explanations 
for the difference are: 1) only four fish per treatment were analysed in Paper 
V; 2) there was a different fatty acid composition of the flaxseed oils used in 
the two studies, as the ALA/LA ratio was only 1.8 and 0.6 in the 
FSO/FSO+S and MO/MO+S diets, respectively, compared with 3.6 and 
1.0 in the study by Trattner et al. (2008); 3) only sesamin was used in Paper 
V, whereas an equimixture of sesamin and episesamin was used by Trattner 
et al. (2008). Episesamin has been reported to be a stronger lipid modulator 
than sesamin in rats (Kushiro et al., 2002). 
The flaxseed oil was purified to obtain flaxseed triacylglycerols in order 
to test the theory that a high ALA/LA ratio and/or minor components in 
flaxseed oil have an inhibitory effect on desaturation and elongation of ALA. 
If minor components in flaxseed oil had interfered with elongation and 
desaturation of ALA, one would have expected the PFSO diet to be more 
efficient in increasing n-3 desaturation indices than the FSO diet. One could 
possibly also have expected the PFSO to be more efficient than MO due to 
higher substrate availability. Moreover, the PFSO+S diet works in the 
opposite direction to FSO+S. Thus, instead of inhibitory substances in the 
flaxseed oil, the results from this study point toward synergistic effects 
between sesamin and minor compounds in the sunflower oil and possibly 
also in the whole flaxseed oil. The results support the theory that the high 
ALA/LA ratio in flaxseed oil has a negative effect on n-3 HUFA formation 
(Tocher et al., 2002). The behaviour of the PFSO+S diet could then be 
explained by a lack of minor compounds that work synergistically with 
sesamin, combined with a high level of ALA. However, the stronger effect 
on the increase in n-3 HUFA observed by Trattner et al. (2008) when using 
flaxseed oil with a higher ALA/LA ratio compared with this study does not 
support the hypothesis of Tocher et al. (2002) that high ALA/LA ratios 
inhibit the conversion of ALA into n-3 HUFA.   53 
4.2.2  Sesamin and tocopherols 
When comparing individual data for rainbow trout white muscle TAGs, a 
negative correlation (P=0.05) was found between sesamin content and n-3 
HUFA/ALA, indicating that increased desaturation and elongation of fatty 
acids is correlated to decreased muscle sesamin. According to Trattner et al. 
(2008), the MO+S diet resulted in lower tissue sesamin levels than the 
FSO+S diet. Together, these results suggest that increased n-3 HUFA/ALA 
is coupled to sesamin metabolism.  
Diets containing sesamin were associated with lower levels of γ-
tocopherol in white muscle of rainbow trout in Paper V, contradicting 
studies on rats and humans where sesamin was associated with increased 
blood and tissue concentrations of γ-tocopherol (Yamashita et al., 1992; 
Frank  et al., 2008). There was also a negative correlation between n-3 
HUFA/ALA and γ-tocopherol (P=0.03) in individual muscle PL data, and a 
tendency for the same in TAGs (P=0.06) in this study. This is in line with a 
study by Bell et al. (2000), where hepatocytes from salmon deficient in α-
tocopherol and/or astaxanthin showed an increased ability to elongate and 
desaturate ALA and EPA.    54 
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5  Main findings and conclusions 
Work related to the lignan oligomer of flaxseed 
¾  An HPLC method for determination of SDG in flaxseed was developed 
and used to compare the SDG content of 29 flaxseed cultivars.  
 
¾  Full spectroscopic data were obtained for 4-O-β-D-glucopyranosyl-p-
coumaric acid and 4-O-β-D-glucopyranosyl-ferulic acid isolated from 
flaxseed.  
 
¾  The linear structure of flaxseed SDG-HMGA oligomers with an average 
molecular weight of 4 kDa was described for the first time.  
 
¾  The first solid evidence that flaxseeds of different cultivars contain 
oligomers of different sizes was presented.  
 
¾  Results from chromatographic analyses, which were selective for 
phenolic compounds (recorded at 280 nm), provided support that the 
molecular size of flaxseed lignan oligomers increases with increasing SDG 
to CoAG ratios. MALDI-TOF MS results showed that Vimy, a flaxseed 
cultivar with very low proportions of hydroxycinnamic acids, had a 
larger average oligomer size than cultivars with higher proportions of 
hydroxycinnamic acids. 
 
¾  The size of flaxseed lignan oligomers was shown to be partly influenced 
by end-capping by hydroxycinnamic acids, possibly at early stages of seed 
development. It was postulated that biosynthesis of the oligomeric 
constituents at different stages of seed maturation leads to formation of 
different populations of oligomers.    56 
 
Work related to flaxseed oil 
¾  The results obtained in this study confirmed findings by Trattner et al. 
(2008) that sesamin added to diets containing flaxseed oil, or a mixture of 
flaxseed and sunflower oil, is able to increase the conversion of alpha-
linolenic acid to highly unsaturated omega-3 fatty acids (n-3 HUFA) in 
white muscle of rainbow trout (Oncorhynchus mykiss).  
 
¾  Diets containing purified triacylglycerols from flaxseed oil used for the 
first time, with and without added sesamin, behaved in the opposite way 
to whole flaxseed oil with and without sesamin, respectively, in terms of 
fatty acid composition of white muscle in rainbow trout. The reason for 
this was unclear, but it may be due to minor bioactive components in 
vegetable oils working synergistically with sesamin. 
 
¾  The difference in the ability of sesamin to increase omega-3 highly 
unsaturated fatty acids (HUFA) in white muscle of rainbow trout when 
comparing flaxseed oil and a mixture of flaxseed oil and sunflower oil 
could not be attributed solely to the proposed inhibitory effects of the 
high ALA/LA ratio of flaxseed oil.  
 
¾  Both sesamin and γ-tocopherol levels were shown to be inversely related 
to increased omega-3 HUFA levels in white muscle of rainbow trout.  
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6   Future perspectives 
Work related to the lignan oligomer of flaxseed 
¾  The studies on differences in oligomer size in different flaxseed cultivars 
need to be followed up by extensive studies comparing the flaxseed 
cultivar Vimy to other cultivars using hulls instead of whole meal and 
monitoring biosynthesis during seed development.  
 
¾  Knowledge about the structure of flaxseed oligomers and their 
components is of great importance from a nutritional and biochemical 
point of view and is crucial for complete understanding and possible 
exploitation. 
Work related to flaxseed oil in fish feed 
¾  To evaluate and understand the effects obtained in this work, larger 
studies with a broader approach, e.g. using OMIC technologies, have to 
be performed. 
 
¾  In order to understand and compare different studies on the effects of 
vegetable oil diets on the fatty acid composition of fish, it is necessary to 
describe the nature of the oils used, e.g. level of refinement and minor 
constituents.   58 
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